Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021 News provided by Share this article Share this article CAMBRIDGE, Mass., Feb. 11, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present a corporate overview at the LifeSci Partners Precision Oncology Day taking place virtually on February 17, 2021. A recording of the presentation will be available to view after the conference under the "Events" tab on the investor relations section of the Cogent Biosciences website at: https://investors.cogentbio.com/events.